| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/12/2009 | WO2009019758A1 Method for isolating renal stem/progenitor cell, renal stem/progenitor cell and therapeutic agent for renal disease |
| 02/12/2009 | WO2009019320A2 Method for inducing and accelerating cells |
| 02/12/2009 | WO2009019314A1 Transferrin variants and conjugates |
| 02/12/2009 | WO2009019312A2 Anti cd37 antibodies |
| 02/12/2009 | WO2009019010A1 Follicular fluid stem cells, methods for their isolation and their use, and culture media |
| 02/12/2009 | WO2009018847A1 Device and method for detaching cells |
| 02/12/2009 | WO2009018832A1 Method for increasing the plasticity level of a cell |
| 02/12/2009 | WO2009018626A1 A therapeutic protocol using stem cells in tissue and neuronal repair, maintenance, regeneration and augmentation |
| 02/12/2009 | WO2009002811A3 Therapeutic platelet compositions and methods |
| 02/12/2009 | WO2008153813A3 Bone augmentation utilizing muscle-derived progenitor compositions, and treatments thereof |
| 02/12/2009 | WO2008145603A3 Pharmaceutical compositions comprising telomerase, and uses thereof |
| 02/12/2009 | WO2008145400A3 Mutated structural protein of a parvovirus |
| 02/12/2009 | WO2008145338A3 Monoclonal antibodies against claudin-18 for treatment of cancer |
| 02/12/2009 | WO2008140863A3 Local field stimulation for cell training of a biological pacemaker |
| 02/12/2009 | WO2008137629A4 Identifying germline competent embryonic stem cells |
| 02/12/2009 | WO2008122770A3 Nucleic acids and libraries for use in functional analysis of regulatory rnas such as micrornas (mirnas) |
| 02/12/2009 | WO2008113770A3 Anti-androgen peptides and uses thereof in cancer therapy |
| 02/12/2009 | WO2008094178A3 Models for vaccine assessment |
| 02/12/2009 | WO2008060792A9 Novel cells, compositions, and methods |
| 02/12/2009 | WO2007108003A3 Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy |
| 02/12/2009 | WO2007080591A3 Adult stem cell-derived connective tissue progenitors for tissue engineering |
| 02/12/2009 | WO2007080590A3 Human embryonic stem cell-derived connective tissue progenitors for tissue engineering |
| 02/12/2009 | WO2007077563A3 Solid-fluid composition |
| 02/12/2009 | WO2007077560A3 Cryoprotective compositions and methods of using same |
| 02/12/2009 | US20090044293 Plants with altered root architecture, involving the rt1 gene, related constructs and methods |
| 02/12/2009 | US20090044288 Transgenic plants with enhanced agrnomic traits |
| 02/12/2009 | US20090044286 Estrogen receptor intramolecular folding systems, estrogen receptor intramolecular folding sensors, methods of use thereof, methods of detecting ER ligands, and methods of detecting ER agonists and antagonists |
| 02/12/2009 | US20090043399 Use of fucans for the purpose of bone grafting, engineering and regeneration |
| 02/12/2009 | US20090042980 Neuroprotective compositions and methods |
| 02/12/2009 | US20090042890 Heteroaryl compounds, compositions thereof, and methods of treatment therewith |
| 02/12/2009 | US20090042852 Novel Pyridine Compounds |
| 02/12/2009 | US20090042837 Leptomycin B; antiproliferative agents; antitumor agents; antcarcinogenic agents; inhibiting the export of a protein from the nucleus of a cell via a CRM1-mediated process; tissue-targeted therapy; cancer of human breast, lung, ovaries, prostate, and bladder, and leukemia cell |
| 02/12/2009 | US20090042830 Novel oncogene, recombinant protein derived therefrom, and uses thereof |
| 02/12/2009 | US20090042822 Method to enhance delivery of glutathione and atp levels in cells |
| 02/12/2009 | US20090042804 Novel peptide amphiphiles having improved solubility and methods of using same |
| 02/12/2009 | US20090042803 Inhibitors of protein kinases and uses thereof |
| 02/12/2009 | US20090042797 Gamma-heregulin |
| 02/12/2009 | US20090042796 Derivatives of the il-2 receptor gamma chain, their production and use |
| 02/12/2009 | US20090042794 Group b streptococcus antigens and corresponding dna fragments |
| 02/12/2009 | US20090042792 18 human secreted proteins |
| 02/12/2009 | US20090042789 Method for Improving Symptom of Mood Disorder |
| 02/12/2009 | US20090042787 Proteolytically cleavable fusion proteins with high molar specific activity |
| 02/12/2009 | US20090042786 Kunitz-type recombinant inhibitor |
| 02/12/2009 | US20090042785 Compound with Affinity for the Cytotoxic T Lymphocyte-Associated Antigen (Ctla-4) |
| 02/12/2009 | US20090042780 Modified TGF-Beta Superfamily Polypeptides and Related Methods |
| 02/12/2009 | US20090042778 Methods for Suppressing Neovascularization Using Ephrinb2 |
| 02/12/2009 | US20090042777 G-CSF Transferrin Fusion Proteins |
| 02/12/2009 | US20090042772 Compounds and methods of treating insulin resistance and cardiomyopathy |
| 02/12/2009 | US20090042296 Transfection ready eukaryotic cells |
| 02/12/2009 | US20090042295 Cell culture substrate and its production method |
| 02/12/2009 | US20090042294 Hydroxyphenyl cross-linked macromolecular network and applications thereof |
| 02/12/2009 | US20090042293 Cell Culture Apparatus, Cell Culture Method, Cell Culture Program and Cell Culture System |
| 02/12/2009 | US20090042292 B7-DC Variants |
| 02/12/2009 | US20090042291 Using Fc gamma RIIb specific immunoglobulin as antiproliferative agent; tissue targeted therapy; immunotherapy |
| 02/12/2009 | US20090042290 Method of modifying a macromolecule without prior extraction from a sample |
| 02/12/2009 | US20090042289 Preservation of Cells |
| 02/12/2009 | US20090042288 Method of Producing Organotypic Cell Cultures |
| 02/12/2009 | US20090042287 Pdx1 expressing endoderm |
| 02/12/2009 | US20090042286 Use of the aca glycoprotein for obtaining/maintaining pluripotent non-embryonic stem cells |
| 02/12/2009 | US20090042285 Antibodies at T cell receptor mimics, methods of production and uses thereof |
| 02/12/2009 | US20090042284 Method for labeling/separation of cells and agent for labeling/separation of cells |
| 02/12/2009 | US20090042283 Optimized messenger rna |
| 02/12/2009 | US20090042250 Methods and compositions for inactivating alpha 1,6 fucosyltransferase (FUT8) gene expression |
| 02/12/2009 | US20090042247 N-acetylglucosaminyltransferase vb coding sequences, recombinant cells and methods |
| 02/12/2009 | US20090042239 Particle Fusing Systems and Methods Using Acoustic Radiation Pressure |
| 02/12/2009 | US20090042233 Novel protein member of the ras/mapk pathway, antibodies thereof and methods and kits of using same |
| 02/12/2009 | US20090042226 Identification and cloning of a full-length human CLNK-related gene, MIST (MAST cell immunoreceptor signal transducer) |
| 02/12/2009 | US20090042225 Method for selecting therapeutic agents for cancer treatment |
| 02/12/2009 | US20090042221 Preparing biopsy of tumorous tissue and monitoring chemosensitivity to anticarcinogenic agents; antitumor agents; drug screening |
| 02/12/2009 | US20090042220 Kit comprising epitope specific immunoglobulin for use in diagnosis/prognosis of bone disorders; Antiarthritic agents; screenning for osteoarthritis |
| 02/12/2009 | US20090042216 Method for purifying proteins and/or biomolecule or protein complexes |
| 02/12/2009 | US20090042199 Nucleotide sequences coding lymphocyte adhesion protein for use in treatment of autoimmunity, inflammation and infection |
| 02/12/2009 | US20090042188 Agent for Differentiating Hematopoietic Stem Cell Into Natural Killer Cell Comprising Vdup1 Protein or Gene Encoding the Same, and a Method of Differentiating Hematopoietic Stem Cell Into Natural Killer Cell Using Thereof |
| 02/12/2009 | US20090042181 Expresion vector comprising hepatitis C viral sequences for use in development and evaluation of antiviral drugs; drug screening |
| 02/12/2009 | US20090041877 Composition comprising growth factor of xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof |
| 02/12/2009 | US20090041867 Estrogenic extracts of ligustrum lucidum ait. of the oleaceae family and uses thereof |
| 02/12/2009 | US20090041854 Parathyroid and thymus transplantation in digeorge syndrome subjects |
| 02/12/2009 | US20090041851 Composition for the delivery of live cells and methods of use thereof |
| 02/12/2009 | US20090041836 Glycolipopeptide and uses thereof |
| 02/12/2009 | US20090041825 Cell culture well-plates having inverted colloidal crystal scaffolds |
| 02/12/2009 | US20090041822 Tissue transplant construct for the reconstruction of a human or animal organ |
| 02/12/2009 | US20090041803 Dioscorea Extracts |
| 02/12/2009 | US20090041796 Surface protein of leptospira |
| 02/12/2009 | US20090041794 Identification of Hla-A2-Presented T-Cell Epitopes Derived from the Oncofoetal Antigen-Immature Laminin Receptor Protein and Uses Thereof |
| 02/12/2009 | US20090041793 Immunostimulatory Compositions and Uses Thereof |
| 02/12/2009 | US20090041792 Dendritic cells, uses therefor, and vaccines and methods comprising the same |
| 02/12/2009 | US20090041788 Apo-2L receptor agonist and CPT-11 synergism |
| 02/12/2009 | US20090041784 Compositions and methods relating to glucagon receptor antibodies |
| 02/12/2009 | US20090041783 Anti-platelet membrane glycoprotein vi monoclonal antibody |
| 02/12/2009 | US20090041777 G-protein specific immunoglobulin targeting and treatment of viral disorders; Drug screening |
| 02/12/2009 | US20090041769 Extracellular domain of CTLA4, with (a) methionine at position 27 and ending with aspartic acid at position 150 (b) an alanine at position 26 and ending with aspartic acid at position 150 ; binds CD80 and/or CD86 with greater avidity; lupus, lupus erythematosus, and lupus nephritis |
| 02/12/2009 | US20090041766 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 02/12/2009 | US20090041761 Method of immunizing animal, composition for immunization, method for producing antibody, method for producing hybridoma and method for producing monoclonal antibody |
| 02/12/2009 | US20090041758 Modified binding molecules comprising connecting peptides |
| 02/12/2009 | US20090041756 121p1f1: a tissue specific protein highly expressed in various cancers |
| 02/12/2009 | US20090041754 Method for identifying target protein of drug and method for screening therapeutic agent for diabetes using the target protein |
| 02/12/2009 | US20090041749 Compositions and methods for the diagnosis and treatment of tumor |
| 02/12/2009 | US20090041745 Modulators of paraptosis and related methods |
| 02/12/2009 | US20090041742 Human dnase ii |
| 02/12/2009 | US20090041740 Cancer treatment by metabolic modulations |